Taiwan FDA registration 5b60caaa4d98f41ec03cf68a0b5afba8

BioMérieux Trial Gradient Strip Antibiotic Susceptibility Test - Bibecillin/Da Suxostatin

TW: 生物梅里埃易特試梯度條抗生素感受性檢測 - 必倍西林/達梭抑黴素
Taiwan flagTaiwan·Risk Class 2·bioMérieux SA·Registered Jul 22, 2019 – Jul 22, 2024Expired
Registration details
Analysis ID
5b60caaa4d98f41ec03cf68a0b5afba8
Customs Code
DHA05603246703
Company information
Manufacturer
bioMérieux SA
Manufacturer Country
France
Product details
Intended Use
This product is a manual quantitative detection technique for antibiotic susceptibility, which can be used to determine the minimum inhibitory concentration of Piperacillin/Tazobactam in μg/mL for Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.1640 抗菌感受性試驗粉末
Import Information
QMS/QSD;; 輸入
Dates and status
Registration Date
Jul 22, 2019
Expiry Date
Jul 22, 2024
Cancellation Date
Oct 15, 2024
About this record

Access comprehensive regulatory information for BioMérieux Trial Gradient Strip Antibiotic Susceptibility Test - Bibecillin/Da Suxostatin in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5b60caaa4d98f41ec03cf68a0b5afba8 and manufactured by bioMérieux SA. The authorized representative in Taiwan is Hong Kong Commercial Mérieux S.p.A. Taiwan Branch.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices